TAK-637 is a tachykinin 1 (NK1) receptor antagonist, and identified as a clinical candidate for the treatment of bladder function disorder. References: Tarui N, Ikeura Y, Natsugari H, Nakahama K. Microbial synthesis of three metabolites of a tachykinin receptor antagonist, TAK-637. J Biosci Bioeng. 2001;92(3):285-7. PubMed PMID: 16233097.

纯度：≥98%

CAS：217185-75-6